Description
Abizol (Aripiprazole) Tablets 10 mg. №28
Ingredients:
Each tablet contains 10 mg of aripiprazole.
Mechanism of Action:
Aripiprazole functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. This unique pharmacological profile leads to the stabilization of dopamine and serotonin levels in the brain, resulting in symptom improvement in patients with schizophrenia and bipolar disorder.
Pharmacological Properties:
The pharmacological properties of Abizol stem from aripiprazole’s interactions with key neurotransmitter receptors, ultimately modulating neurotransmission in a manner that alleviates symptoms associated with schizophrenia and bipolar disorder.
Indications for Use:
Abizol tablets are specifically indicated for the management of schizophrenia and bipolar disorder. They are effective in addressing symptoms such as hallucinations, delusions, and mood fluctuations in patients diagnosed with these conditions.
Contraindications:
Abizol should not be administered to individuals with known hypersensitivity to aripiprazole or any components of the tablet formulation. Additionally, it is contraindicated in patients with a history of neuroleptic malignant syndrome.
Side Effects:
Common side effects associated with Abizol may include nausea, dizziness, weight gain, and somnolence. Patients should consult their healthcare provider if these side effects persist or worsen.
Usage Instructions:
The recommended dosage of Abizol is 10 mg taken once daily, with adjustments permitted based on individual response to treatment. The tablets should be taken orally, with or without food, and should not be crushed or chewed.
Benefits Compared to Analogues:
Abizol distinguishes itself from analogues through its unique mechanism of action, which combines partial agonism and antagonism at specific receptors to achieve a balanced modulation of neurotransmitter levels. This targeted approach contributes to improved symptom management and overall treatment outcomes.
Suitable Patient Groups:
Abizol is suitable for use in various patient populations, including adults, elderly individuals, and adolescents, under the supervision of a qualified healthcare professional. Dosing adjustments may be necessary based on age and individual health considerations.
Storage and Shelf Life:
Abizol tablets should be stored at room temperature, away from moisture and heat. The shelf life of the product is typically indicated on the packaging and should be adhered to for optimal efficacy.
Packaging Description:
Abizol tablets are typically packaged in blister packs to ensure individual tablet integrity and facilitate convenient dosing. The packaging may contain information regarding dosage instructions, expiration date, and manufacturer details.
Clinical Evidence and Proven Effectiveness:
Scientific studies, such as those published in reputable journals like the Journal of Clinical Psychopharmacology, have demonstrated the efficacy of aripiprazole in treating schizophrenia and bipolar disorder. These studies highlight the positive impact of aripiprazole on symptom reduction and quality of life improvement in affected individuals.
For further information on the clinical evidence supporting the use of aripiprazole in the treatment of schizophrenia and bipolar disorder, refer to the following study: View Study